Why the study?
Are plasma suPAR levels associated with mortality, admission time, and Charlson Comorbidity Index in acutely admitted medical patients?
Are plasma suPAR levels associated with mortality, admission time, and Charlson Comorbidity Index in acutely admitted medical patients?
Plasma suPAR levels are associated with disease severity, admission time, and mortality in acutely admitted medical patients, suggesting potential utility in prognostic algorithms.
suPAR associated with mortality in acute admissions; leaves open its utility in prognostic algorithms pending validation.
SuPAR is a marker of disease severity, admission time, and risk of mortality in a heterogeneous cohort of patients with a variety of diseases. The independent value of suPAR suggests it could be of value in prognostic algorithms.
No takes yet. Share an insight, caveat, or question.
Haupt et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: